- Previous Close
3.0200 - Open
2.9800 - Bid 2.7200 x --
- Ask 2.7400 x --
- Day's Range
2.5200 - 2.9800 - 52 Week Range
1.6000 - 18.0000 - Volume
7,478 - Avg. Volume
4,718 - Market Cap (intraday)
5.91M - Beta (5Y Monthly) 2.21
- PE Ratio (TTM)
-- - EPS (TTM)
-7.2300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
European Institute of Science AB (publ) manufactures and sells diagnostic assays for the clinical laboratory and point-of-care settings, and point-of-care instrumentation for diagnostic applications in Sweden. It primarily focuses on the diagnostic assays and instrumentation for canine, feline, and equine animals. The company's products include TurboReader point-of-care instruments that performs measurements using disposable cuvettes; Canine C-Reactive (CRP) TurboReader assays for the quantitative determination of Canine CRP in dog serum or plasma; Feline Hp (Haptoglobin) TurboReader assay for determining Hp in cat serum or plasma; Feline SAA TurboReader assay for the determination of serum amyloid A (SAA) in cat serum or plasma; and Equine SAA TurboReader assay for determining SAA in horse serum or plasma. In addition, it provides Abacus Vet5 hematology analyzer for use in veterinary clinics and research; pancreas elastase 1 quick canine tests for detecting canine pancreatic elastase1 in stool samples; Equine ALB, an in vitro immune nephelometric assay for the quantitative determination of Albumine (ALB) in horse serum or plasma; Equine U-ALB, an in vitro immune nephelometric assay for the quantitative determination of Albumine (U-ALB) in horse urine; and EurisTest turbidimetric assay canine CRP and canine CRP lateral flow assays. European Institute of Science AB (publ) was incorporated in 1990 and is based in Lund, Sweden.
www.euris.orgRecent News: EURI-B.ST
View MorePerformance Overview: EURI-B.ST
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EURI-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EURI-B.ST
View MoreValuation Measures
Market Cap
5.66M
Enterprise Value
4.71M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.27
Price/Book (mrq)
4.39
Enterprise Value/Revenue
6.15
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-277.62%
Return on Assets (ttm)
-40.67%
Return on Equity (ttm)
-67.33%
Revenue (ttm)
930.87k
Net Income Avi to Common (ttm)
-2.58M
Diluted EPS (ttm)
-7.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
354k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.85M